|
Market Closed -
Nasdaq
00:00:00 21/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.660 USD | +4.40% |
|
+1.84% | -48.61% |
Evolution of the Average Target: Alaunos Therapeutics, Inc.
Evolution of the Target Price: Alaunos Therapeutics, Inc.
Changes in Analyst Recommendations: Alaunos Therapeutics, Inc.
0e209cc4175778128cec6ba524.Gfx3qvYxIQY_KTrAANOYa9MKSkYxhlTOjrBk5iOBdkk.aKQN-cZwckt8Z1eOWbTSAqI8LiVDwiWE6IFX1GLIFH8tuC__jmZJRFYEWQ~26a2a3d35657ab3b6776c0d824511d69
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
| +43.71% | ||||||
| +19.51% | ||||||
| +11.58% | ||||||
| +20.93% | ||||||
| +26.88% | ||||||
| +30.99% | ||||||
| +70.4% | ||||||
| +20.93% | ||||||
| +37.4% | ||||||
| Average | +31.37% | |||||
| Weighted average by Cap. | +30.28% |


Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.660
Average target price
-
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- TCRT Stock
- Consensus Alaunos Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















